Japan Adds iPS Parkinson’s Therapy to Public Insurance at ¥55.3M Per Patient
Japan's iPS Parkinson's therapy enters public insurance at ¥55.3M per patient, forcing global insurers to rethink experimental exclusion clauses.
Topic
Japan's iPS Parkinson's therapy enters public insurance at ¥55.3M per patient, forcing global insurers to rethink experimental exclusion clauses.
Egypt's FRA issued Decision No. 70 in May 2026, introducing three takaful operating models and mandatory Sharia boards — a governance overhaul for a…
S&P Global Ratings cut Acrisure Holdings' outlook to Negative in Q1 2026, citing integration pressures and an emerging litigation cluster. The signal tests the…
EIOPA AI governance opinion mandates two-step impact assessments for EU insurers by August 2026, with €35M penalties for non-compliance with the EU AI Act.
Hong Kong's Insurance Authority closes RBC consultation extending infrastructure capital relief to general insurers and imposing a 100% crypto charge. Implementation target: December 31,…
Munich Re Q1 2026 posted €1.7bn net profit as P&C reinsurance revenue contracted 20%, signalling deliberate underwriting discipline. What tightened guidance means for H2…
FEMA Review Council backs private market expansion in NFIP reform push, urging a 2-3 year transition as the program's $22.5B debt mounts toward the…
Lloyd’s governance probe into former CEO John Neal puts London Market transparency standards to the test as Chair resists disclosure while Freshfields investigators press…
EIOPA finalises revised Solvency II supervisory guidelines effective January 2027: 26% fewer quarterly templates, a 21% risk margin reduction, and mandatory DORA compliance embedded…
FCA claims management review launched May 6, targeting misleading ads, unfair exit fees and unauthorized sign-ups—making Consumer Duty compliance in claims handling an active…